High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial

Torsten O Nielsen; Maj-brit Jensen; Samantha Burugu; Dongxia Gao; Charlotte Levin Tykjaer Jörgensen; Eva Balslev; Bent Ejlertsen

doi:10.1158/1078-0432.CCR-16-1278

High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial

Torsten O Nielsen, Maj-brit Jensen, Samantha Burugu, Dongxia Gao, Charlotte Levin Tykjaer Jörgensen, Eva Balslev, Bent Ejlertsen

The Danish Breast Cancer Cooperative Group (DBCG)

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Originalspråk	engelska
Sidor (från-till)	946-953
Tidskrift	Clinical Cancer Research
Volym	23
Nummer	4
DOI	https://doi.org/10.1158/1078-0432.CCR-16-1278
Status	Published - 2017
Externt publicerad	Ja

FN:s Globala mål

Denna forskningsoutput relaterar till följande Globala mål

Tillgång till dokument

10.1158/1078-0432.CCR-16-1278

Citera det här

Nielsen, T. O., Jensen, M., Burugu, S., Gao, D., Levin Tykjaer Jörgensen, C., Balslev, E., & Ejlertsen, B. (2017). High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial. Clinical Cancer Research, 23(4), 946-953. https://doi.org/10.1158/1078-0432.CCR-16-1278

@article{4b797ce8f53b430984668178baf4150c,

title = "High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial",

author = "Nielsen, {Torsten O} and Maj-brit Jensen and Samantha Burugu and Dongxia Gao and {Levin Tykjaer J{\"o}rgensen}, Charlotte and Eva Balslev and Bent Ejlertsen",

year = "2017",

doi = "10.1158/1078-0432.CCR-16-1278",

language = "English",

volume = "23",

pages = "946--953",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research",

number = "4",

}

Nielsen, TO, Jensen, M, Burugu, S, Gao, D, Levin Tykjaer Jörgensen, C, Balslev, E & Ejlertsen, B 2017, 'High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial', Clinical Cancer Research, vol. 23, nr. 4, s. 946-953. https://doi.org/10.1158/1078-0432.CCR-16-1278

High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial. / Nielsen, Torsten O; Jensen, Maj-brit; Burugu, Samantha et al.
I: Clinical Cancer Research, Vol. 23, Nr. 4, 2017, s. 946-953.

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

TY - JOUR

T1 - High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial

AU - Nielsen, Torsten O

AU - Jensen, Maj-brit

AU - Burugu, Samantha

AU - Gao, Dongxia

AU - Levin Tykjaer Jörgensen, Charlotte

AU - Balslev, Eva

AU - Ejlertsen, Bent

PY - 2017

Y1 - 2017

U2 - 10.1158/1078-0432.CCR-16-1278

DO - 10.1158/1078-0432.CCR-16-1278

M3 - Article

C2 - 27601592

SN - 1078-0432

VL - 23

SP - 946

EP - 953

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 4

ER -